• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT LABORATORIES PRISM HBSAG CONF; PRISM HBSAG CONFIRMATORY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT LABORATORIES PRISM HBSAG CONF; PRISM HBSAG CONFIRMATORY Back to Search Results
Catalog Number 06E51-68
Medical Device Problem Code False Positive Result (1227)
Health Effect - Clinical Code No Known Impact Or Consequence To Patient (2692)
Date of Event 01/12/2017
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
(b)(6).An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.
 
Event or Problem Description
The customer stated that suspected (b)(6) confirmatory results were generated.A sample was initially tested with prism hbsag on (b)(6) 2016 and a (b)(6) result of (b)(6) was generated.The sample was repeated in duplicate and (b)(6) results of (b)(6) were generated.Prism hbsag confirmatory testing was performed on (b)(6) 2017 and a nonconfirming result was generated with a (b)(6) and a % neutralization of -30.17.The customer inadvertently performed confirmatory testing again on (b)(6) 2017 and a confirmed (b)(6) result was generated with a (b)(6) and a % neutralization of 67.03.No further testing was performed on the sample.The sample was from a first time donor that had received the (b)(6) 18 months prior.There was no report of adverse impact to patient management.
 
Additional Manufacturer Narrative
Field data for abbott prism hbsag lot 67099m500 was evaluated.A total of 2,217,127 samples were tested across multiple customer sites and the initial and repeat reactive rates were 0.04% and 0.01%, respectively, which are less than the abbott prism hbsag package insert upper 95% confidence intervals of 0.09% and 0.06%.The lot is meeting labeling claims for clinical specificity.A review of the device history records for the likely cause lot did not reveal any issues related to the customer's observations.Customer complaint data was reviewed and no adverse trends were identified.The prism hbsag and prism hbsag confirmatory reagent package inserts were reviewed and were found to adequately address the issue.The investigation did not identify a product deficiency.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PRISM HBSAG CONF
Common Device Name
PRISM HBSAG CONFIRMATORY
Manufacturer (Section D)
ABBOTT LABORATORIES
100 abbott park road
abbott park IL 60064 3500
MDR Report Key6347243
Report Number1415939-2017-00014
Device Sequence Number11009080
Product Code KSJ
UDI-Device Identifier00380740062972
UDI-Public(01)00380740062972(17)170207(10)62001M500
Combination Product (Y/N)N
Initial Reporter StateIN
Initial Reporter CountryUS
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source health professional
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 04/21/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date02/07/2017
Device Catalogue Number06E51-68
Device Lot Number62001M500
Was Device Available for Evaluation? No
Type of Report(Section G)FDA Requested
Initial Date Received by Manufacturer 01/27/2017
Supplement Date Received by ManufacturerNot provided
Initial Report FDA Received Date02/21/2017
Supplement Report FDA Received Date04/22/2017
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
PRISM ANALYZER 06A36-04, SN (B)(4); PRISM HBSAG 06D19-68, LOT 67099M500
-
-